What is Pivot Bio?
Founded in 2010 and headquartered in Berkeley, California, Pivot Bio is at the forefront of agricultural innovation. The company specializes in improving the plant microbiome by enabling plants to fix nitrogen directly from the atmosphere, thereby reducing the need for synthetic fertilizers. This approach not only offers environmental benefits by decreasing greenhouse gas emissions associated with fertilizer production and use but also provides a more sustainable and cost-effective solution for farmers. Pivot Bio's technology represents a significant advancement in crop nutrition and sustainable farming practices, positioning it as a key player in the future of agriculture.
How much funding has Pivot Bio raised?
Pivot Bio has raised a total of $616.7M across 5 funding rounds:
Private Equity
$749K
Series A
$16M
Series B
$70M
Series C
$100M
Series D
$430M
Private Equity (2014): $749K, investors not publicly disclosed
Series A (2016): $16M, investors not publicly disclosed
Series B (2018): $70M supported by Temasek and Breakthrough Energy Ventures
Series C (2020): $100M featuring DCVC Management, Temasek, Tekfen Ventures, Roger Underwood, Spruce Capital Partners, Bunge Ventures, CGC, Alan Cohen, Pavilion Capital, Codon Capital, Prelude Ventures, and Breakthrough Energy Ventures
Series D (2021): $430M, investors not publicly disclosed
Key Investors in Pivot Bio
Temasek
Temasek is a global investment company headquartered in Singapore, known for its generational investment approach and focus on making a positive impact.
Breakthrough Energy Ventures
Breakthrough Energy Ventures invests in cutting-edge companies aimed at achieving net-zero emissions, with a focus on sectors like agriculture and energy.
DCVC Management
DCVC is a deep tech venture capital firm that invests in entrepreneurs tackling significant global challenges, particularly in areas like AI, biotechnology, and agriculture.
What's next for Pivot Bio?
With significant enterprise-level investment, Pivot Bio is poised for accelerated growth and market penetration. The substantial capital infusion is expected to fuel further research and development, scale manufacturing capabilities, and expand its commercial reach globally. The company's strategic focus on sustainable agriculture and its innovative nitrogen-fixing technology align with increasing global demand for environmentally friendly farming solutions. Future developments will likely involve broader adoption of its products, potential expansion into new crop types, and continued refinement of its microbial solutions to address evolving agricultural challenges and contribute to a more sustainable food system.
See full Pivot Bio company page
